November 19, 2021

Study introduces new strategy to treat advanced liver cancer

Advanced liver cancer, or hepatocellular carcinoma (HCC), currently has limited treatment options and poor prognosis • A recent study introduces a new approach to treat advanced HCC by combining systemic immunotherapy with internal radiation therapy Advanced liver cancer, or hepatocellular carcinoma (HCC), currently has limited treatment options and poor prognosis A recent study introduces a new approach to treat advanced […]

admin Health 0 3 min read
October 6, 2021

Phase III KEYNOTE-394 trial of Keytruda meets primary endpoint in hepatocellular carcinoma – Merck Inc

Merck Inc announced that the Phase III KEYNOTE-394 trial investigating Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in Asian patients with advanced hepatocellular carcinoma (HCC) previously treated with sorafenib met its primary endpoint of overall survival (OS). The study found that treatment with Keytruda plus best supportive care resulted in a statistically significant improvement in OS compared with placebo plus best supportive […]

admin Health 0 55 sec read

Recent Posts

Meta

Categories

Archives

Recent Comments